Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Sarcoma, Kaposi 3HIV Infections 2Acquired Immunodeficiency Syndrome 2Weight Loss 1Triple Negative Breast Neoplasms 1Thrombocytopenia 1Splenomegaly 1Skin Neoplasms 1Sarcoma 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphocytosis 1Lymphadenopathy 1Leukemia, Lymphocytic, Chronic, B-Cell 1Glioblastoma 1Fever 1Fatigue 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Brain Metastases From Solid Tumors 1Anemia 1Advanced Breast Cancer 1AIDS-related Kaposi sarcoma 1

Interventions

Tamoxifen 12Chemotherapy, Adjuvant 9Radiotherapy 7Anastrozole 6Neoadjuvant Therapy 5Magnetic Resonance Spectroscopy 5Letrozole 5Gene Expression Profiling 5Psychiatric Rehabilitation 4Mass Spectrometry 4Immunohistochemistry 4Early Intervention, Educational 4Counseling 4Sentinel Lymph Node Biopsy 3Reverse Transcriptase Polymerase Chain Reaction 3High-Energy Shock Waves 3Fatty Acids, Omega-3 3Chromatography, High Pressure Liquid 3Biopsy 3afimoxifene 2Trastuzumab 2Surgical Procedures, Operative 2Soybean Proteins 2Simvastatin 2Radiotherapy, Conformal 2Radiation 2Methods 2Mastectomy 2Fish Oils 2Caregivers 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Intraductal, Noninfiltrating × Ritonavir × Clear all
NCT01009437 2017-12-05

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Masonic Cancer Center, University of Minnesota

Phase 1 Completed
28 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡